Compare LGVN & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGVN | TKLF |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | Japan |
| Employees | N/A | 160 |
| Industry | Medicinal Chemicals and Botanical Products | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 8.4M |
| IPO Year | 2021 | 2020 |
| Metric | LGVN | TKLF |
|---|---|---|
| Price | $1.39 | $1.51 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $61.25 | N/A |
| AVG Volume (30 Days) | ★ 151.7K | 11.5K |
| Earning Date | 11-03-2026 | 07-10-2026 |
| Dividend Yield | N/A | ★ 15.31% |
| EPS Growth | ★ 50.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $709,000.00 | N/A |
| Revenue This Year | $46.15 | N/A |
| Revenue Next Year | $396.46 | N/A |
| P/E Ratio | ★ N/A | $2.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $1.30 |
| 52 Week High | $7.60 | $3.62 |
| Indicator | LGVN | TKLF |
|---|---|---|
| Relative Strength Index (RSI) | 28.36 | 41.38 |
| Support Level | $0.60 | $1.30 |
| Resistance Level | $7.30 | $1.63 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 0.69 | 63.64 |
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.